AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
New Fortress Energy
NFE
Cars.com
CARS
4
Halozyme Therapeutics
HALO
5
Collegium Pharmaceutical
COLL
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -1.92%7.34B | |||||||||
Net income from continuing operations | ---- | ---- | ---- | ---- | ---- | 38.23%6.05B | ---- | ---- | ---- | ---- |
Operating gains losses | ---- | ---- | ---- | ---- | ---- | -132.20%-137M | ---- | ---- | ---- | ---- |
Depreciation and amortization | ---- | ---- | ---- | ---- | ---- | -13.45%1B | ---- | ---- | ---- | ---- |
Other non cash items | ---- | ---- | ---- | ---- | ---- | -23.61%-932M | ---- | ---- | ---- | ---- |
Change In working capital | ---- | ---- | ---- | ---- | ---- | -64.61%786M | ---- | ---- | ---- | ---- |
-Change in receivables | ---- | ---- | ---- | ---- | ---- | -122.52%-204M | ---- | ---- | ---- | ---- |
-Change in inventory | ---- | ---- | ---- | ---- | ---- | -30.00%7M | ---- | ---- | ---- | ---- |
-Change in payables and accrued expense | ---- | ---- | ---- | ---- | ---- | -92.16%52M | ---- | ---- | ---- | ---- |
-Change in other current assets | ---- | ---- | ---- | ---- | ---- | 600.00%85M | ---- | ---- | ---- | ---- |
-Change in other current liabilities | ---- | ---- | ---- | ---- | ---- | 28.38%846M | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 40.04%10.28B | 25.44%2.48B | 50.24%2.17B | 42.43%2.94B | 45.03%2.69B | -1.92%7.34B | -20.73%1.98B | 15.10%1.44B | 66.56%2.07B | -25.74%1.85B |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -28.84%-1.86B | |||||||||
Net PPE purchase and sale | ---- | ---- | ---- | ---- | ---- | -94.12%-165M | ---- | ---- | ---- | ---- |
Net intangibles purchase and sale | ---- | ---- | ---- | ---- | ---- | -3.20%-999M | ---- | ---- | ---- | ---- |
Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | 139.58%57M | ---- | ---- | ---- | ---- |
Net investment purchase and sale | ---- | ---- | ---- | ---- | ---- | -163.00%-860M | ---- | ---- | ---- | ---- |
Net other investing changes | ---- | ---- | ---- | ---- | ---- | -650.00%-22M | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -265.97%-6.82B | 786.01%1.32B | -192.21%-3.34B | 151.76%693M | -777.93%-5.5B | -28.84%-1.86B | 82.58%-193M | 8.13%-1.14B | -208.51%-1.34B | 346.50%811M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 55.02%-1.54B | |||||||||
Net issuance payments of debt | ---- | ---- | ---- | ---- | ---- | 10.77%-116M | ---- | ---- | ---- | ---- |
Net common stock issuance | ---- | ---- | ---- | ---- | ---- | 61.68%-1.2B | ---- | ---- | ---- | ---- |
Cash dividends paid | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Proceeds from stock option exercised by employees | ---- | ---- | ---- | ---- | ---- | -186.67%-43M | ---- | ---- | ---- | ---- |
Net other financing activities | ---- | ---- | ---- | ---- | ---- | -85.71%-65M | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -149.02%-3.83B | -41.49%-815M | -3.89%-882M | -4,781.82%-1.61B | -552.50%-522M | 55.02%-1.54B | -50.39%-576M | 49.10%-849M | 96.61%-33M | 79.75%-80M |
Net cash flow | ||||||||||
Beginning cash position | 41.99%13.57B | -17.54%10.21B | -5.40%12.25B | -15.76%10.22B | 41.99%13.57B | 44.97%9.56B | 44.27%12.38B | 28.93%12.95B | 45.21%12.13B | 44.97%9.56B |
Current changes in cash | -109.48%-373M | 147.43%2.99B | -273.45%-2.05B | 191.51%2.03B | -229.07%-3.33B | 50.46%3.94B | 20.44%1.21B | 66.85%-550M | -53.73%695M | 45.93%2.58B |
Effect of exchange rate changes | -139.47%-30M | -54.55%-34M | 163.16%12M | -94.44%7M | -66.67%-15M | -78.16%76M | 26.67%-22M | -109.64%-19M | -33.33%126M | -12.50%-9M |
End cash Position | -2.97%13.16B | -2.97%13.16B | -17.54%10.21B | -5.40%12.25B | -15.76%10.22B | 41.99%13.57B | 41.99%13.57B | 44.27%12.38B | 28.93%12.95B | 45.21%12.13B |
Free cash flow | 66.45%10.28B | 205.04%2.48B | 50.24%2.17B | 42.43%2.94B | 45.03%2.69B | -3.97%6.17B | -43.58%813M | 15.10%1.44B | 66.56%2.07B | -25.74%1.85B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |